Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-125712

Options or other derivatives

  • SVP & Chief Operating Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nicholson John · SVP & Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-06-01 Grant or award : show line 1 in the form Stock Option +100,000 $15.53 2024-05-31 100,000 100,000 D
Loading xslF345X03/doc4.xml…